A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American College of Cardiology

• Publication date

  2003-12-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2003.07.017PMID 14662245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

  2002cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

  2001cited by this paper
• Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

  2000cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

  2000cited by this paper
• Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

  2000cited by this paper
• Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial

  1999cited by this paper
• Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction

  1999cited by this paper
• A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial.

  1998cited by this paper
• Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction.

  1998cited by this paper
• Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

  1998cited by this paper
• In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction.

  1998cited by this paper
• Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction

  1998cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

  1998cited by this paper
• Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction.

  1997cited by this paper
• TIMI frame count: a quantitative method of assessing coronary artery flow.

  1996cited by this paper
• Differences in treatment of acute myocardial infarction by sex, age, and other factors (the Stanford Five-City Project).

  1996cited by this paper
• A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results.

  1994cited by this paper
• Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

  1989cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

  1985cited by this paper
• The thrombolysis in myocardial infarction (TIMI) trial.

  1985cited by this paper

• Inhibiteurs de la glycoprotéine IIbIIIa

  2026cites this paper
• Therapeutic interventions for coronary microvascular obstruction after acute myocardial infarction: Developments and challenges.

  2026cites this paper
• Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta‐Analysis of Randomized Trials

  2024cites this paper
• Age and sex-related differences in epidemiology, treatment, and mortality of patients with ST-segment elevation myocardial infarction in Iran

  2023cites this paper
• Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention

  2023cites this paper
• Reperfusion injury in acute ischemic stroke: Tackling the irony of revascularization.

  2023cites this paper
• What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?

  2023cites this paper
• The emerging role of adopting protamine for reducing the risk of bleeding complications during the percutaneous coronary intervention: A meta‐analysis

  2022cites this paper
• Antiplatelet Therapy in Coronary Artery Disease: Now and Then

  2022cites this paper
• Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials

  2022cites this paper
• Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI

  2022cites this paper
• What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?

  2020cites this paper
• Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis.

  2019cites this paper
• Challenges and unanswered questions in STEMI management.

  2019cites this paper
• Differential Risk of ST-Segment Elevation Myocardial Infarction in Male and Female Smokers.

  2019cites this paper
• Comparison of Routine Versus Selective Glycoprotein IIb/IIIa Inhibitors Usage in Primary Percutaneous Coronary Intervention (from the British Cardiovascular Interventional Society).

  2019cites this paper
• Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction

  2018cites this paper
• Inhibiteurs de la glycoprotéine IIbIIIa

  2018cites this paper
• Ischemia-reperfusion injury: Complex pathophysiology with elusive treatment.

  2018cites this paper
• Glycoprotein IIb/IIIa Antagonists

  2017cites this paper
• Antiplatelet therapy in acute coronary syndrome

  2017cites this paper
• Antithrombotic therapy for patients with STEMI undergoing primary PCI

  2017cites this paper
• Strategies in mechanical interventions for acute MI: facilitated and rescue PCI

  2017cites this paper
• Comparison of Angioplasty With Infusion ofTirofibanorAbciximabandWithImplantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction

  2017cites this paper
• Balloon Angioplasty or BMS

  2016cites this paper
• Role of Parenteral Agents in PCI for Stable Patients

  2016cites this paper
• Post-Infarct Cardiomyopathy : Why it is the Last Challenge in ST Elevation Myocardial Infarction ?

  2016cites this paper
• Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI.

  2016cites this paper
• A CTUALIZACIÓN Y F UTURO D EL Ó XIDO N ÍTRICO EN E L T RATAMIENTO D E L A E NFERMEDAD C ARDIOVASCULAR

  2016cites this paper
• Reflow and the uest to Achieve Optimal erfusion During the Acute hase of Myocardial Infarction

  2016cites this paper
• Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling

  2016cites this paper
• The Role of Tirofiban in Percutaneous Coronary Interventions and Primary Angioplasty

  2016cites this paper
• Platelet Glycoprotein IIb/IIIa Inhibitor Tirofiban Ameliorates Cardiac Reperfusion Injury.

  2015cites this paper
• articleTriple antiplatelet therapy for preventing vascular events : a systematic review and meta-analysis

  2015cites this paper
• Percutaneous Coronary Interventions in Stable and Acute Coronary Syndromes: Stent technology, lesion complexity and clinical outcome

  2015cites this paper
• Intracoronary vs intravenous abciximab in interventional cardiology: A reopened question?

  2015cites this paper
• Impact of upstream high bolus dose tirofiban on left ventricular systolic function in patients with acute anterior myocardial infarction treated by primary coronary intervention

  2014cites this paper
• Myocardial Ischaemia-Reperfusion Syndrome

  2014cites this paper
• Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors

  2014cites this paper
• Adjunctive Pharmacology for Coronary Intervention

  2014cites this paper
• Effect of intracoronary tirofiban on platelet alpha-granule membrane protein and myocardial perfusion level during emergency percutaneous coronary intervention.

  2014cites this paper
• Evaluation of the effect of integrilin in primary coronary angioplasty on mortality and echocardiography findings in patients with acute myocardial infarction

  2014cites this paper
• Life is what happens to you while you´re busy making other plans

  2014cites this paper
• Antiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a retrospective observational study of prasugrel and clopidogrel.

  2014cites this paper
• Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register

  2014cites this paper
• Myocardial 'no-reflow' prevention.

  2013cites this paper
• Outcome after percutaneous coronary intervention

  2013cites this paper
• Role of Parenteral Agents in Percutaneous Coronary Intervention for Stable Patients.

  2013cites this paper
• ST-segment Elevation Myocardial Infarction 2 What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?

  2013cites this paper
• Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis

  2013cites this paper
• αIIbβ3 (GPIIb-IIIa) Antagonists

  2013cites this paper
• Short-term effect of upstream administration in comparison to deferred injection of tirofiban on patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2013cites this paper
• Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

  2013cites this paper
• Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

  2013cites this paper
• Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations

  2013cites this paper
• Monitoring and Reversal of Anticoagulation and Antiplatelets.

  2013cites this paper
• Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention

  2013cites this paper
• The year in interventional cardiology.

  2013cites this paper
• Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high‐risk patients with ST elevation myocardial infarction—a meta‐regression of randomized controlled trials

  2013cites this paper
• Prehospital Abciximab in ST-Segment Elevation Myocardial Infarction: Results of the Randomized, Double-Blind MISTRAL Study

  2012cites this paper
• Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention.

  2012cites this paper
• Paramedic administration of glycoprotein inhibitors for ST elevation myocardial infarction

  2012cites this paper
• Glycoprotein IIb/IIIa Inhibitors

  2012cites this paper
• THE SECRETOME OF MONONUCLEAR CELLS AS A THERAPEUTIC TOOL IN MYOCARDIAL INFARCTION AND MYOCARDITIS : AN EXPERIMENTAL STUDY

  2012cites this paper
• Contemporary use of glycoprotein IIb/IIIa inhibitors

  2012cites this paper
• Antiplatelet agents in ischemic heart disease.

  2012cites this paper
• Management and Outcome in ST-Elevation Myocardial Infarction from a Gender Perspective

  2012cites this paper
• Pharmacotherapy During Percutaneous Coronary Interventions

  2012cites this paper
• Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials

  2012cites this paper
• Reperfusion Therapy in Acute ST-elevation Myocardial Infarction

  2012cites this paper
• Cardiovascular Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A

  2012cites this paper
• Antiplatelet Agents

  2012cites this paper
• Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis

  2012cites this paper
• 11 Pharmacotherapy During Percutaneous Coronary Interventions

  2012cites this paper
• Strategies to improve outcome in patients with ST elevation myocardial infarction treated with primary PCI

  2012cites this paper
• on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions the American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of

  2012cites this paper
• Transradial Approach for Coronary Interventions: The New Gold Standard for Vascular Access?

  2012cites this paper
• Efficacy and Safety of Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Revascularization for an Acute Coronary Syndrome: A Meta‐Analysis of Randomized Trials Performed With Stents and Thienopyridines

  2012cites this paper
• Additive benefit of glycoprotein IIb/IIIa inhibition and adjunctive thrombus aspiration during primary coronary intervention: results of the Initial Thrombosuction and Tirofiban Infusion (ITTI) trial.

  2012cites this paper
• Erratum zu: Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“

  2011cites this paper
• Comparative efficacy of eptifibatide and abciximab in primary angioplasty study

  2011cites this paper
• Heparin, LMWH, GIIb/IIIa, and Direct Thrombin Inhibitors

  2011cites this paper
• Tc-99m SPECT Sestamibi for the Measurement of Infarct Size

  2011cites this paper
• Papel del tirofibn en la sala de hemodinmica y en la angioplastia primaria

  2011cites this paper
• Myocardial Protection via the Coronary Venous Route

  2011cites this paper
• ST Elevation Myocardial Infarction

  2011cites this paper
• Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

  2011influential citation
• Effects of postconditioning in ST-elevation myocardial infarction: Assessment of myocardium at risk and infarct size

  2011cites this paper
• Cardiology—In‐Depth Look: Advances in Antiplatelet Therapy

  2011cites this paper
• Vigencia de los inhibidores de la glucoproteína IIb/IIIa en el tratamiento de los síndromes coronarios agudos

  2011cites this paper
• Synergy between pharmacological and mechanical reperfusion in ST-segment elevation myocardial infarction patients: 2011 update

  2011cites this paper
• Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction.

  2011cites this paper
• Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction

  2011cites this paper
• Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• Adverse outcomes after primary PCI

  2011cites this paper
• ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

  2011cites this paper
• Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function

  2011cites this paper
• Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.

  2011cites this paper
• Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

  2011cites this paper